Systemic administration of anti-interleukin-10 antibody prolongs organ allograft survival in normal and presensitized recipients.
Systemic administration of anti-interleukin-10 antibody prolongs organ allograft survival in normal and presensitized recipients. Transplantation. 1998 Dec 27; 66(12):1587-96.